Simplex Trading
ETON icon

Simplex Trading’s Eton Pharmaceutcials ETON Stock Holding History

Simplex Trading’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$481K Buy
19,500
+19,300
+9,650% +$337K ﹤0.01% 3311
2025
Q4 		$3.38K Sell
200
-12,400
-98% -$218K ﹤0.01% 7628
2025
Q3 		$273K Buy
+12,600
New +$209K ﹤0.01% 4594
2025
Q2 		– Sell
-3,600
Closed -$46K – 8925
2025
Q1 		$46K Buy
+3,600
New +$54.4K ﹤0.01% 5849
2022
Q3 		– Sell
-2,500
Closed -$6K – 10153
2022
Q2 		$6K Sell
2,500
-3,300
-57% -$11.1K ﹤0.01% 8714
2022
Q1 		$25K Buy
5,800
+100
+2% +$393 ﹤0.01% 7982
2021
Q4 		$24K Sell
5,700
-100
-2% -$478 ﹤0.01% 8146
2021
Q3 		$36K Hold
5,800
– – ﹤0.01% 7908
2021
Q2 		$35K Buy
5,800
+5,725
+7,633% +$42.4K ﹤0.01% 8076
2021
Q1 		$54K Buy
+75
New +$640 ﹤0.01% 6514

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return

Simplex Trading's ETON Position: Q2 2025 in Review

Simplex Trading sold out of Eton Pharmaceutcials (ETON) in Q2 2025, closing a stake of 4,472 shares — an estimated $70.7K sold.

Simplex Trading first reported a position in ETON in Q1 2021 and held it in 6 quarters. The position peaked at $484K in Q4 2024. 87 funds tracked by Wall St. Rank hold ETON as of Q2 2025.

  • Simplex Trading reported no remaining Eton Pharmaceutcials position as of Q2 2025 after selling out during the quarter.
  • Simplex Trading sold 4,472 Eton Pharmaceutcials shares in Q2 2025, an estimated $70.7K.
  • Simplex Trading first reported a position in Eton Pharmaceutcials in Q1 2021 and held it in 6 quarters.
  • Simplex Trading's Eton Pharmaceutcials position peaked at $484K in Q4 2024.
  • 87 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2025.

Based on Simplex Trading's 13F filing for Q2 2025, filed 5 Aug 2025.